Maintenance Allergy Shots Do NOT Start with Red Vials
Maintenance allergy shots begin with the maintenance concentrate preparation itself, not with any color-coded vial system. The concept of "red vials" is not a standardized component of allergen immunotherapy protocols described in clinical guidelines.
Understanding the Maintenance Phase
The maintenance phase of subcutaneous immunotherapy (SCIT) begins when the effective therapeutic dose is reached, following completion of the build-up phase 1. Here's how it actually works:
What Defines Maintenance
- The maintenance concentrate is the preparation containing individual extracts or mixtures of allergen extracts at concentrated doses intended for treatment 1
- The maintenance dose is the specific dose that provides therapeutic efficacy without significant adverse reactions 1
- Once this dose is reached, injection intervals are increased (typically every 2-4 weeks for inhalant allergens) 1
Practical Dosing Approach
Current evidence-based practice typically uses:
- 5-mL maintenance vials containing 0.2 mL of manufacturer's extract of each allergen 2
- Patients receive 0.5-mL injections from these maintenance vials 2
- This dosing achieves 5-20 μg of major allergen per injection, which falls within the probable effective dose range 2
Common Pitfall to Avoid
There is no universal color-coding system for immunotherapy vials in standard practice. While some individual practices may use their own color-coding systems for organizational purposes (such as distinguishing different dilution strengths during build-up), this is not part of established guidelines 1, 3. The maintenance phase is defined by dose and interval, not vial color.
What Actually Matters
Focus on these critical elements instead: